Rather & Kittrell’s Amgen AMGN Stock Holding History

Rather & Kittrell’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-6	Closed	-$1K	–	74
2021 Q4	$1K	Buy	+6	New	+$1.27K	﹤0.01%	293

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Rather & Kittrell's AMGN Position: Q1 2022 in Review

Rather & Kittrell sold out of Amgen (AMGN) in Q1 2022, closing a stake of 6 shares — an estimated $1K sold.

Rather & Kittrell first reported a position in AMGN in Q4 2021 and held it in 1 quarter. The position peaked at $1K in Q4 2021. 2,338 funds tracked by Wall St. Rank hold AMGN as of Q1 2022.

Rather & Kittrell reported no remaining Amgen position as of Q1 2022 after selling out during the quarter.
Rather & Kittrell sold 6 Amgen shares in Q1 2022, an estimated $1K.
Rather & Kittrell first reported a position in Amgen in Q4 2021 and held it in 1 quarter.
Rather & Kittrell's Amgen position peaked at $1K in Q4 2021.
2,338 funds tracked by Wall St. Rank held Amgen as of Q1 2022.

Based on Rather & Kittrell's 13F filing for Q1 2022, filed 10 May 2022.